Comunicati.net - Comunicati pubblicati - Aziende Comunicati.net - Comunicati pubblicati - Aziende Mon, 30 Mar 2020 02:06:20 +0200 Zend_Feed_Writer 1.12.20 (http://framework.zend.com) http://comunicati.net/comunicati/aziende/1 Offshore Lubricants Industry - Trends, Size, Share, Growth, Demand and Regional Outlook by 2023 Sat, 28 Mar 2020 06:11:22 +0100 http://comunicati.net/comunicati/aziende/informatica/information_technology/626518.html http://comunicati.net/comunicati/aziende/informatica/information_technology/626518.html Market Research Future Market Research Future Market Research Future published a half-cooked research report on global Offshore Lubricants market. The Offshore Lubricants market is expected to grow at ~ 3.5% CAGR during the period 2017 to 2023.

Market Highlights:

Offshore Lubricants market is predominantly driven by the increasing offshore exploration and production investment across the world. The rise in demand for energy and the depletion of onshore reserves have made the oil & gas companies to significantly invest in the offshore oil & gas reserves. The evolution in drilling activities and the rise in the demand from the offshore rigs and FPSO (Floating, Production, Storage and Offloading Vessels) are likely to boost the demand for offshore lubricants.

Lubricants have a vital impact on the maintenance costs and the service life of the components.   The investment in lubricant may be relatively small, but it can make a great difference. Lubricants producers across the world work in close cooperation with manufacturers of important components and shipping industry equipment to extend service intervals and components life while increasing operational reliability. Reducing the impact on the environment is important to the shipping and offshore industry. As a shipping operator, it has become essential to be aware of the expanding body of environmental regulations affecting their business. Additionally, a growing interest in ecological issues is propelling the customers to demand environmentally sound operating process.

Get a Free Sample @ https://www.marketresearchfuture.com/sample_request/5520

The global attention towards reducing the stream of mineral oil-based lubricants entering the oceans, harbours and inland waters from standard operational practices, is a major challenge for marine operators. According to U.S. Environmental Protection Agency, several million litres more are projected to be discharged other on-deck and through stern tube leakage alone. Additionally, millions of litres more are estimated to be discharged through other on-deck and hull machine elements such as cranes, winches stabilizers, and bow thrusters.

The global Offshore Lubricants Industry is expected to grow at ~ 3.5% CAGR during the forecast period.

Key Players:

The key players of global offshore lubricants market are:

  • Gulf Oil Corporation
  • Royal Dutch Shell plc
  • BP plc
  • Chevron Corporation
  • Exxon Mobil Corporation
  • Total S.A.
  • Aegean Marine Petroleum
  • Fuchs Petrolub SE
  • Idemitsu Kosan Co.,Ltd.
  • JXTG Nippon Oil & Energy Corporation

Market Research Analysis:

Engine oil and OSVs (Offshore Support Vehicles) are, expected to grow at the highest CAGR and hold the largest market share.

Global Offshore Lubricant Market has been segmented based on application, end-use, and region. Engine oil segment by application currently holds the largest share and is expected to dominate the offshore lubricants market during the forecast period. Engine oils are widely used in vessel engines, boat engines, and container engine. Engine oils play a crucial role in assisting engines to ideal efficiency in their output. These oils are required specifically for speed and stoke cycle of engines. Engine oils prevent engines from rusting, wear and tear. Growing maritime activities across the globe are expected to drive engine oils demand over the forecast period. The OSVs segment by end-use held the largest market share, in 2016 and is expected to hold the largest share over the forecast period. OSVs are largely used as support systems for offshore drilling and production sectors. Increasing utilization of OSVs due to rising deep water reserves exploration, and production will give rise to greater maintenance, resulting in higher demand for lubricants such as engine oils, compressor oils, transmission oils, gear oils and hydraulic fluids.

Browse key industry insights spread across 139 pages with 148market data tables & 6 figures & charts from the report, “Offshore Lubricants Industry Information, by Application (Engine oil, Hydraulic oil, Gear oil, and Grease), by End-Use (Offshore rigs, FPSO (Floating, Production, Storage and Offloading Vessels), and OSVs (Offshore Support Vehicles)) and by Region - Global Forecast to 2023.” in detail along with the table of contents @ https://www.marketresearchfuture.com/reports/offshore-lubricants-market-5520

Scope of the Report:

This study provides an overview of the global offshore lubricants market, tracking two market segments across four geographic regions. The report studies key players, providing a five-year annual trend analysis that highlights market size, volume and share for North America, Europe, Asia Pacific (APAC) and Rest of the World (ROW). The report also provides a forecast, focusing on the market opportunities for the next five years for each region. The scope of the study segments the offshore lubricants market by its application, by end-use and by region.

]]>
Kyphosis Market analysis Overview by Top Companies Analysis, Upcoming Trends, Emerging Growth, Segments and Forecast to 2025 Sat, 28 Mar 2020 05:28:01 +0100 http://comunicati.net/comunicati/aziende/trasporti/626517.html http://comunicati.net/comunicati/aziende/trasporti/626517.html Market Research Future Market Research Future Global Kyphosis Market Research Report: By Type (Postural Kyphosis, Scheuermann's Kyphosis, Congenital Kyphosis), Diagnostic Test & Diseases (X-ray, Biopsy, Aspirin, Ibuprofen, Naproxen, Spinal Fusion), End User (Hospitals, Diagnostic Centres, Research Organizations) - Forecast till 2025

OTIS Biotech Korea (Republic of Korea), Taeyeon Medical Co., Ltd (Republic of Korea), SURGI R&D (Republic of Korea), Medtronic, Depromed Inc. (Republic of Korea), BMKOREA (Republic of Korea), EC21 Inc. (Republic of Korea), and others are some of the leading players at the cutting edge of the competition in Kyphosis Market analysis  and are profiled in MRFR Analysis. 

Global Kyphosis Market - Overview

Kyphosis is the condition in which back is exaggerated forward rounding owing to weakness in the spinal bones that crack or compress them. It can happen at any age but mostly genetic population get effected with kyphosis.This deformity can be caused by variety of problems such as osteoporosis, disk degeneration, birth defects, cancer in the spine, etc. The condition can also be caused by poor posture which can cause pain and breathing difficulties. It is a medical condition marked by the rounding of the back, which is normal with aging. Kyphosis is estimated to occur at any age. But a majority of the patients belongs the geriatric population. The condition is often related with osteoporosis. The Kyphosis can by type is classified into postural kyphosis, scheuermann's kyphosis, congenital kyphosis, and others. Some of the common symptoms of the diseases are inclusive of back pain and stiffness of the back account 24% of the total population

Global Kyphosis Market - Competitive Analysis

There are numerous players operating in the kyphosis market globally such as OTIS Biotech Korea (Republic of Korea), Taeyeon Medical Co., Ltd (Republic of Korea), SURGI R&D (Republic of Korea), Medtronic, Depromed Inc. (Republic of Korea), BMKOREA (Republic of Korea), EC21 Inc. (Republic of Korea) and others. Also, players are increasingly expanding their involvement in the developing region, making it difficult for regional vendors to compete with them, especially in terms of features such as portfolios, quality, and pricing. Most of the players involve in collaboration, acquisition, expansion, product launch, and partnership to lead the market and to maintain their market position.

Global Kyphosis Market - Regional Analysis

On regional basis, Global Kyphosis Market is segmented into four major regions namely Americas, Europe, Asia Pacific and the Middle East and Africa. Americas leads the Global Kyphosis Market owing the presence of well-developed economies like U.S. and Canada and a well-developed healthcare sector. Europe accounts for the second largest Global Kyphosis Market. Asia Pacific is estimated to be the fastest growing market. Japan and Australia are the major contributor for the market. Moreover, the presence of the developing economies like India have the have opportunities for the market growth. Middle East & Africa accounts the lowest share in the market due to presence of poor economies and present political conditions. Saudi Arabia, UAE, and Kuwait are the major contributor for the market growth in the Middle East & Africa.

Get full report @https://www.marketresearchfuture.com/reports/kyphosis-market-1760

Related reports

 hematuria treatment market size

Wearable Sensors Market

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services

]]>
Ischemic Strokes Market Value Chain, Factor Analysis, Region and Forecasts Till 2023 Sat, 28 Mar 2020 05:00:56 +0100 http://comunicati.net/comunicati/aziende/tecnologia/626515.html http://comunicati.net/comunicati/aziende/tecnologia/626515.html Market Research Future Market Research Future Market Research Future published a study report on Global Ischemic strokes Market. This report studies the global market size, industry status and forecast, competition landscape and growth opportunity. Ischemic strokes Market research report categorizes the market by companies, region, type and end-use industry.

Market Scenario:

Ischemic strokes occur as a result of an obstruction within a blood vessel supplying blood to the brain. The underlying condition of this type of obstruction is the development of fat deposits lining the vessel walls, which is known as atherosclerosis. According to the World Health Organization (WHO), stroke accounts for around 17 million deaths annually. As per the Centers for Disease Control and Prevention (CDC), stroke leads to 1 out of every 20 deaths costing around USD 34 billion each year in the U.S. Higher rates of mortality associated with strokes highlight an impending need for innovative drugs and diagnostic devices.

The key strategies adopted by leading industry players incldues new product launches and collaborations. For instance, in April 2016, the novel TransCarotid Artery Revascularization (TCAR) procedure launched by Silk Road Medical, Inc, received FDA approval. This minimally invasive technique is designed to access the common carotid artery. Moreover, in March, 2015, WATCHMAN, a closure device designed to prevent stroke in patients with atrial fibrillation received FDA approval.

Rising cases of ischemia stroke are driving the demand for surgical procedures in stroke treatment. Increasing demand for minimally invasive procedures and advancements in surgical procedures are the key factors boosting the growth of the global ischemic stroke market. High cost of the surgical procedures and excessive usage of medication for the treatment of ischemic stroke are hindering the market growth.

The Ischemic strokes Market is expected to grow at a CAGR of approximately 8.3% during the forecast period 2017-2023.


Market Segmentation of Ischemic strokes Market:

The ischemic stroke is segmented on the basis of diagnosis, drug class, surgery and end-users. On the basis of the diagnosis, the market is segmented into Computed Tomography (CT), Magnetic resonance imaging (MRI), carotid ultrasound, cerebral angiography, electrocardiography, echocardiography, and others. On the basis of the drug class, the market is segmented into tissue plasminogen activator, anticoagulant, antiplatelet, antihypertensive, and others On the basis of the surgery, the market is segmented into carotid endarterectomy, angioplasty, and endovascular mechanical thrombectomy On the basis of the end-user, the market is segmented into hospitals & clinics, medical institutes, research organization, and others.


Top Players in Ischemic strokes Market:

Abbott Laboratories (U.S.), Medtronic plc (U.S.), Boston Scientific Corporation (U.S.), Cordis Corporation (U.S.), Koninklijke Philips N.V. (Netherland), GE Healthcare (U.S.), Stryker Corporation (U.S.), Genentech, Inc. (U.S.), Merck & Co., Inc. (U.S.), Bayer AG (Germany), Boehringer Ingelheim (Germany), Sanofi (France), Covidien plc (Ireland), Philips Healthcare (U.S.), Johnson & Johnson (U.S.), Penumbra, Inc. (U.S.), GE Healthcare (U.S.), Siemens Healthcare (U.S.), Hitachi, Ltd (Japan), Biogen (U.S.), Daiichi Sankyo (U.S.), Pfizer Inc. (U.S.), and others

The emergence of new and cost-effective medication options for the treatment of ischemic stroke could open up new opportunities to the new players in the global ischemic stroke market. Additionally, emerging markets, such as India and China, could also open new opportunities to new players.

Intended Audience

  • Ischemic Stroke Drug Suppliers
  • Ischemic Stroke Drug Manufacturers
  • Research and Development (R&D) Companies
  • Medical Research Laboratories
  • Academic Medical Institutes and Universities

Regional Analysis of Ischemic strokes Market:

The global ischemic stroke market consists of countries namely America, Europe, Asia Pacific, and the Middle East and Africa.
The Americas has emerged as the largest market for the global ischemic stroke owing to the favorable government initiatives, technological innovations, and increasing demand for ischemic stroke products. According to the American Heart Association, ischemic stroke is among the top three causes of death in the U.S. and Canada, nearly 795,000 patients suffering from strokes are treated in the 2014.

Europe is the second largest global ischemic stroke market owing to the advancements in the surgical devices technology along with the rising occurrence of acute ischemia stroke cases among the patients. In the European Union, over 31 million people are living with diabetes aged between 20 and 79. This signifies an average diabetes prevalence rate of 8.6% of the adult population. Some other factors driving the market includes the growing percentage of diabetes mellitus population mainly in the developed countries of Europe
Asia Pacific is anticipated to unfold as the most promising market for the global ischemic stroke owing to increasing prevalence of stroke cases in this region. China and India are considered as a big market for ischemic stroke within the forecast period. Manufacturers are expanding their operations in Asia Pacific region as these regions hold immense potential for the market growth.

The Middle East region is expected to grow at a faster rate due to the factors such as the extensive development of healthcare infrastructure and growing emphasis on research and development in the healthcare sector.

get full report @https://www.marketresearchfuture.com/reports/ischemic-stroke-market-5423


About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

]]>
Ischemic Strokes Market Value Chain, Factor Analysis, Region and Forecasts Till 2023 Sat, 28 Mar 2020 05:00:34 +0100 http://comunicati.net/comunicati/aziende/tecnologia/626514.html http://comunicati.net/comunicati/aziende/tecnologia/626514.html Market Research Future Market Research Future Market Research Future published a study report on Global Ischemic strokes Market. This report studies the global market size, industry status and forecast, competition landscape and growth opportunity. Ischemic strokes Market research report categorizes the market by companies, region, type and end-use industry.

Market Scenario:

Ischemic strokes occur as a result of an obstruction within a blood vessel supplying blood to the brain. The underlying condition of this type of obstruction is the development of fat deposits lining the vessel walls, which is known as atherosclerosis. According to the World Health Organization (WHO), stroke accounts for around 17 million deaths annually. As per the Centers for Disease Control and Prevention (CDC), stroke leads to 1 out of every 20 deaths costing around USD 34 billion each year in the U.S. Higher rates of mortality associated with strokes highlight an impending need for innovative drugs and diagnostic devices.

The key strategies adopted by leading industry players incldues new product launches and collaborations. For instance, in April 2016, the novel TransCarotid Artery Revascularization (TCAR) procedure launched by Silk Road Medical, Inc, received FDA approval. This minimally invasive technique is designed to access the common carotid artery. Moreover, in March, 2015, WATCHMAN, a closure device designed to prevent stroke in patients with atrial fibrillation received FDA approval.

Rising cases of ischemia stroke are driving the demand for surgical procedures in stroke treatment. Increasing demand for minimally invasive procedures and advancements in surgical procedures are the key factors boosting the growth of the global ischemic stroke market. High cost of the surgical procedures and excessive usage of medication for the treatment of ischemic stroke are hindering the market growth.

The Ischemic strokes Market is expected to grow at a CAGR of approximately 8.3% during the forecast period 2017-2023.


Market Segmentation of Ischemic strokes Market:

The ischemic stroke is segmented on the basis of diagnosis, drug class, surgery and end-users. On the basis of the diagnosis, the market is segmented into Computed Tomography (CT), Magnetic resonance imaging (MRI), carotid ultrasound, cerebral angiography, electrocardiography, echocardiography, and others. On the basis of the drug class, the market is segmented into tissue plasminogen activator, anticoagulant, antiplatelet, antihypertensive, and others On the basis of the surgery, the market is segmented into carotid endarterectomy, angioplasty, and endovascular mechanical thrombectomy On the basis of the end-user, the market is segmented into hospitals & clinics, medical institutes, research organization, and others.


Top Players in Ischemic strokes Market:

Abbott Laboratories (U.S.), Medtronic plc (U.S.), Boston Scientific Corporation (U.S.), Cordis Corporation (U.S.), Koninklijke Philips N.V. (Netherland), GE Healthcare (U.S.), Stryker Corporation (U.S.), Genentech, Inc. (U.S.), Merck & Co., Inc. (U.S.), Bayer AG (Germany), Boehringer Ingelheim (Germany), Sanofi (France), Covidien plc (Ireland), Philips Healthcare (U.S.), Johnson & Johnson (U.S.), Penumbra, Inc. (U.S.), GE Healthcare (U.S.), Siemens Healthcare (U.S.), Hitachi, Ltd (Japan), Biogen (U.S.), Daiichi Sankyo (U.S.), Pfizer Inc. (U.S.), and others

The emergence of new and cost-effective medication options for the treatment of ischemic stroke could open up new opportunities to the new players in the global ischemic stroke market. Additionally, emerging markets, such as India and China, could also open new opportunities to new players.

Intended Audience

  • Ischemic Stroke Drug Suppliers
  • Ischemic Stroke Drug Manufacturers
  • Research and Development (R&D) Companies
  • Medical Research Laboratories
  • Academic Medical Institutes and Universities

Regional Analysis of Ischemic strokes Market:

The global ischemic stroke market consists of countries namely America, Europe, Asia Pacific, and the Middle East and Africa.
The Americas has emerged as the largest market for the global ischemic stroke owing to the favorable government initiatives, technological innovations, and increasing demand for ischemic stroke products. According to the American Heart Association, ischemic stroke is among the top three causes of death in the U.S. and Canada, nearly 795,000 patients suffering from strokes are treated in the 2014.

Europe is the second largest global ischemic stroke market owing to the advancements in the surgical devices technology along with the rising occurrence of acute ischemia stroke cases among the patients. In the European Union, over 31 million people are living with diabetes aged between 20 and 79. This signifies an average diabetes prevalence rate of 8.6% of the adult population. Some other factors driving the market includes the growing percentage of diabetes mellitus population mainly in the developed countries of Europe
Asia Pacific is anticipated to unfold as the most promising market for the global ischemic stroke owing to increasing prevalence of stroke cases in this region. China and India are considered as a big market for ischemic stroke within the forecast period. Manufacturers are expanding their operations in Asia Pacific region as these regions hold immense potential for the market growth.

The Middle East region is expected to grow at a faster rate due to the factors such as the extensive development of healthcare infrastructure and growing emphasis on research and development in the healthcare sector.

get full report @https://www.marketresearchfuture.com/reports/ischemic-stroke-market-5423


About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

]]>
Insulin Delivery Devices Market 2020 Trends, Size Analysis, Share, Leading Companies, Future-Insights and Top Manufacturers, Forecast To 2025 Sat, 28 Mar 2020 04:49:03 +0100 http://comunicati.net/comunicati/aziende/tecnologia/626513.html http://comunicati.net/comunicati/aziende/tecnologia/626513.html Market Research Future Market Research Future Insulin Delivery Devices Market Size, Application and Trends Analysis By Type (Insulin Syringes, Pen, Insulin Pumps, Insulin Jet Injectors, Pen Needles), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Sales And Diabetes Clinics/ Centers), End User and Region, Forecast Till 2025

The Global Insulin Delivery Devices Market size is estimated to grow at a CAGR of 7.85% and expected to reach USD 21,804 Million by 2025, says Market Research Future (MRFR). Insulin, a glucose directing hormone, assumes a fundamental job in the whole treatment of diabetes. Insulin delivery frameworks help in infusing insulin into the greasy tissue under the skin. Factors, such as developing diabetic populace, innovative headways in insulin delivery systems, and favoring repayment arrangements, expanding mindfulness among shoppers on the accessibility of a few delivery devices and advancement of human insulin devices are relied upon to positively affect the insulin delivery devices market. However, the accessibility of oral insulin as an elective medication delivery technique is probably going to hamper the development of the insulin delivery devices market. Expanding awareness about diabetic consideration is among the drivers for the insulin delivery devices market.

Insulin delivery devices, including traditional syringes, without needle injectors, and auto and pen injectors, have been broadly used for the organization of insulin to treat type 1 diabetes issue. The worldwide market for insulin delivery devices has seen constantly expanding R&D. Following the outlined course, it is anticipated that an expanding commonness of hyperglycemia, developing selection of self-injectable devices, and rising FDA endorsements drive the market development. Be that as it may, the nearness of cross-defilement and expanding cost of top of the line items are assessed to limit the market development during the conjecture time frame

Medtronic Recalls MiniMed Insulin Pumps for Potential Cybersecurity Risks the FDA has distinguished this as a Class I review, the most genuine sort of review. Utilization of these devices may cause genuine wounds or demise the review portrayed in this notice is a similar one that was reported in the FDA Safety Communication from June 27, 2019. Different factors that are driving the worldwide Insulin delivery devices market are developing appropriation of self-injectable devices and expanding FDA endorsements for tranquilize delivery devices.

Insulin Delivery Devices Market Competitive Analysis:

Some of the major key players in the global Insulin Delivery Devices Market include Novo Nordisk A/S, Becton, Dickinson and Company, Medtronic PLC, Eli Lilly, Sanofi, Johnson and Johnson, Biocon Limited, Tandem Diabetes Care, Inc., B. Braun Melsungen AG, and F. Hoffmann-La Roche.

Insulin Delivery Devices Market Segmentation:

By type, the global insulin delivery devices market is segmented into

  • insulin syringes
  • pen
  • pumps
  • insulin jet injectors
  • pen needles

The pen segment is further sub-segmented into reusable

  • insulin pens
  • disposable insulin pens

The pumps segment is further sub-segmented into

  • external/tethered pumps
  • patch pumps

The pen segment comprises

  • standard pen needles
  • safety pen needles

By distribution channel, the global insulin delivery devices market is segmented into

  • hospital pharmacy
  • retail pharmacy
  • online sales
  • diabetes clinics/centers

Based on end user, the global insulin delivery devices market is segmented into

  • hospitals & clinics
  • home care
  • specialty centers

Insulin Delivery Devices Market Regional Analysis:

Regionally, the Insulin Delivery Devices Market is segmented into the Americas, Asia-Pacific, Europe, and Middle East & Africa. Of these, the Americas is foreseen to rule the worldwide insulin delivery devices market inferable from the rising mindfulness about the condition and high social insurance consumption. The area is relied upon to reach USD 21,804.56 million by 2025 at 7.85% CAGR from 2019 to 2025. The Americas represented the biggest provincial market inferable from the developing biotechnology industry, the expanding commonness of diabetes, and a well-created human services segment.

For example, according to the National Diabetes Statistics Report, 2017 distributed by National Center for Chronic Disease Prevention and Health Promotion 30.3 million individuals have diabetes which is 9.4% of the complete populace in the US. These elements are driving the insulin delivery devices market in the Americas. Europe represented the second-biggest market share in 2017 because of broad R&D for medicinal services, expanding subsidizing, and developing appropriation of the innovation inside the area.

Browse Full Research Reports At:  https://www.marketresearchfuture.com/reports/insulin-delivery-devices-market-851

 

Insulin Delivery Devices Market Industry News:

  • Valeritas Holdings, Inc. a therapeutic innovation organization and creator of the V-Go Wearable Insulin Delivery gadget, which utilizes its exclusive h-Patch™ innovation, reported positive information from its preclinical pharmacokinetic.
  • the organization reported an association with Tandem to create future insulin delivery frameworks. While last talks are yet continuous over “specialized execution of gadget combination and related business bolster exercises.

Table of Content:

  • Executive Summary
  • Market Introduction
  • Research Methodology
  • Market Dynamics
  • Market Factor Analysis
  • Insulin Delivery Devices Market, by Type
  • Global Insulin Delivery Devices Market, by Distribution Channel
  • Global Insulin Delivery Devices Market, by End-User
  • Insulin Delivery Devices Market, by Region
  • Company Landscape
  • Company Profiles
  • Appendix
  • LIST OF TABLES

into the US and Canada.

Related Reports

Pseudomonas Aeruginosa treatment market

 

Behavioral Health Services Market 

About Us

MRFR team has supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country-level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Contact:

Market Research Future

https://www.marketresearchfuture.com/

]]>
Global Opioids Market Size Industry Analysis, Growth, Share Segments, Key Innovative Product Develop Sat, 28 Mar 2020 04:38:50 +0100 http://comunicati.net/comunicati/aziende/tecnologia/626512.html http://comunicati.net/comunicati/aziende/tecnologia/626512.html Market Research Future Market Research Future Market Research Future (MRFR) publishes periodic market research report on Opioids Market Information: By Product (Extended-Release/Long-Acting Opioid, Immediate Release/Short Acting Opioid), by Application (Pain Relief, Anesthesia, Cough Suppression, Deaddiction, Others), by End User, and by Region — Global Forecast till 2023

Leading Market Players

Sanofi SA (France), Pfizer Inc. (US), Boehringer Ingelheim GmbH (Germany), Teva Pharmaceutical Industries Ltd (Israel), Allergan Inc. (US), Purdue Pharma L.P. (US), West-Ward Pharmaceuticals Corporation (Jordan), Sun Pharmaceutical Industries Ltd (India), Egalet Corporation (US), Janssen Global Services, LLC (US), Vertice Pharma LLC (UK), Mallinckrodt (Surrey), and others.

Opioids Market Overview

The global opioids market is expected to register a CAGR of 7.12% during the forecast period with a market value of USD 19,554.49 million in 2017. Opioids are a type of narcotic pain medications that are used to treat moderate to severe pain medications. According to the National Health Interview Survey 2017, 25.3 million Americans suffer from chronic pain daily and 23.4 million people reported their pain as severe.

Segmentation Analysis

The global opioids market, by product, has been segmented into extended-release/long-acting opioids and immediate-release/short-acting opioids. The extended-release opioid segment is further segmented into oxycodone, oxymorphone, morphine, hydromorphone, and others. The extended-release opioid segment accounted for a value of USD 12,750.91 million in 2017. The immediate-release opioid segment is further segmented into codeine, hydrocodone, fentanyl, morphine, and others. The market, by application, can be segmented into pain relief, anesthesia, cough suppression, diarrhea suppression, and de-addiction. On the basis of end user, the global opioids market is segmented into hospitals & clinics, pharmacies, and academic research institutes.

Table of Content

4 Market Dynamics

4.1 Introduction

 

4.2 Drivers

4.2.1 Increasing Use Of Opioids For Disease Condition Causing Chronic Pains Such As Cancers, Arthritis, Lower Back Pain, And Fibromyalgia

4.2.2 Favorable Reimbursement Policies For Palliative Care In Developed Regions

4.2.3 Substantial Rise In Road Accidents, Trauma, And Surgical Procedures

4.3 Restraints

4.3.1 Rising Addiction And Death Cases Due To Overdose Of Opioid 26

4.4 Opportunities

4.4.1 Reconsideration Of Prescribing Opioid Analgesics Due To Rising Awareness About Opioids Misuse, Abuse, And Overdose Has Prompted Many Stakeholders

List of Tables

TABLE 1 MARKET SYNOPSIS

TABLE 2 PRIMARY INTERVIEWS

TABLE 3 GLOBAL OPIOIDS MARKET, BY PRODUCT, 2015–2023 (USD MILLION)

TABLE 4 GLOBAL OPIOIDS MARKET FOR EXTENDED-RELEASE OPIOID, BY REGION, 2015–2023 (USD MILLION)

TABLE 5 GLOBAL OPIOIDS MARKET FOR EXTENDED-RELEASE OPIOID, BY TYPE, 2015–2023 (USD MILLION)

Continued…

COLLECT DETAILED INFORMATION OF THE REPORT @ https://www.marketresearchfuture.com/reports/opioids-market-7626

Intended Audience

  • Pharmaceutical Companies
  • Research Institutes
  • Hospitals
  • Academic Institutes

This research report provides insights, on various levels of analysis such as industry analysis, market share analysis, leading market players, and their profiles. This report also helps in studying the target segments by providing views on emerging and high-growth segments and market conclusion. Together the market data comprises and discusses basic assessments on the competitive scenarios and strategies of the global opioids market.

Related News

Sex Cord Gonadal Stromal Tumor Market

 

Bariatric Surgery Devices Market

 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

https://www.marketresearchfuture.com/

]]>
Biopharmaceuticals Market Trends Analysis, Upcoming Trends, Emerging Growth, Key Players Segments and Forecast to 2023 Sat, 28 Mar 2020 04:29:22 +0100 http://comunicati.net/comunicati/aziende/tecnologia/626511.html http://comunicati.net/comunicati/aziende/tecnologia/626511.html Market Research Future Market Research Future Biopharmaceuticals Market Research Report - Global Forecast till 2025 Highlights

According to MRFR analysis, Biopharmaceuticals Market is expected to register a CAGR of 8.99% during the forecast period of 2019 to 2025 and was valued at USD 238,192.7 million in 2018.

Biopharmaceuticals are also known as biological, medical products, or biologics, are pharmaceutical drugs manufactured, extracted, or synthesized using biological sources, such as bacteria, yeast, and mammalian cells.

The global biopharmaceuticals market is growing owing to various factors such as increasing investment by major companies on research & development of biopharmaceuticals and increasing acceptance for biopharmaceuticals due to their ability to treat the previously untreatable diseases. Furthermore, the number of geriatric populations is, tremendously, the incidence rate of chronic diseases is also high, and technological advancements are growing which are also expected to fuel the market growth. However, the entry of low-cost biosimilars, risk of side effects that can occur due to high usage of biopharmaceuticals, and stringent government regulations are expected to pose as restraints to the growth of the global biopharmaceuticals market.

Segmentation

The global biopharmaceuticals market has been segmented based on product type and application.

The global biopharmaceuticals market has been segmented, on the basis of product type, into monoclonal antibodies, recombinant growth factors, purified proteins, recombinant proteins, recombinant hormones, vaccines, synthetic immunomodulators, and others. The recombinant growth factors has been further bifurcated into erythropoietin and granulocyte colony-stimulating factor. The purified proteins segment has been further classified as leukemia inhibitory factor (LIF), P53 protein, P38 protein, and others. The recombinant proteins segment has been further divided into serum albumin, amyloid protein, defensin, transferrin, and others. Vaccines have also been segregated into recombinant vaccines, conventional vaccines, and others. The recombinant vaccines have been further sub-segmented into cancer vaccines, malaria vaccines, Ebola vaccines, hepatitis B vaccines, tetanus vaccines, diphtheria vaccines, cholera vaccines, and others. Conventional vaccines have been categorized as polio vaccines, pox vaccines, and others. Synthetic immunomodulators segment has been further divided into cytokines, interferons, interleukins, tumor necrosis factor (TNF), and others. Monoclonal antibodies segment is anticipated to hold the largest market share in the global biopharmaceutical market due to the increasing number of research activities that are supported by the usage of monoclonal antibodies. Vaccines are expected to grow at the fastest CAGR owing to the rising awareness of chronic diseases.

Key Players

Some of the key players in the Global Biopharmaceuticals Market are Pfizer Inc. (US), Amgen Inc. (US), Eli Lilly and Company (US), F. Hoffmann-La Roche Ltd (Switzerland), Johnson & Johnson (US), Gilead Sciences, Inc. (US), AstraZeneca (UK), Abbvie Inc. (US), Sanofi (France), Bristol-Myers Squibb Company (US), Sandoz International GmbH (Germany), Novo Nordisk A/S (Denmark), GlaxoSmithKline PLC (UK), Merck KGaA (Germany), and Biocon (India).

get full report @https://www.marketresearchfuture.com/reports/biopharmaceuticals-market-8439

Regional Analysis

The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas is expected to be the largest market owing to the increasing prevalence of chronic diseases. The biopharmaceuticals market in the Americas has further been branched into North America and Latin America, with the North American market divided into the US and Canada. The European biopharmaceuticals market has been categorized as Western Europe and Eastern Europe. The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The biopharmaceuticals market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. Due to the increasing patient pool suffering from various chronic diseases and a supportive regulatory framework, the market in Asia-Pacific is expected to be the fastest-growing. The biopharmaceuticals market in the Middle East & Africa has been divided into the Middle East and Africa

Regional Analysis

The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas is expected to be the largest market owing to the increasing prevalence of chronic diseases. The biopharmaceuticals market in the Americas has further been branched into North America and Latin America, with the North American market divided into the US and Canada. The European biopharmaceuticals market has been categorized as Western Europe and Eastern Europe. The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The biopharmaceuticals market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. Due to the increasing patient pool suffering from various chronic diseases and a supportive regulatory framework, the market in Asia-Pacific is expected to be the fastest-growing. The biopharmaceuticals market in the Middle East & Africa has been divided into the Middle East and Africa.

]]>
Infusion Pump Market Size Worth USD 9.71 Billion | CAGR 5% By 2023 Sat, 28 Mar 2020 04:11:40 +0100 http://comunicati.net/comunicati/aziende/tecnologia/626509.html http://comunicati.net/comunicati/aziende/tecnologia/626509.html Market Research Future Market Research Future Infusion Pump Market Share, Trends And Growth Analysis By Type (Volumetric Pump, Syringe Pump, & Others), By Application (Chemotherapy, Diabetes, Gastrointestinal Diseases, Pediatrics & Others), By End User (Hospitals, Ambulatory Surgical Centers, Homecare & Others) - Forecast To 2023

Rising investments in R&D by the leading market players to bring about further innovations and advancements in their existing product range drive the growth of the infusion pump market. Conversely, patient safety concerns, and improper infusion leading to the severe consequences are factors impeding the growth of the market. Moreover, unmet medical needs in underdeveloped countries would act as an obstacle to market growth.

The Global Infusion Pump Market size is anticipated to reach USD 9.71 billion with expanding at a CAGR of 5% throughout the forecast period (2017-2023). Rising use of infusion pump for drug delivery and high requirement of infusion systems in the military medical units predominantly propel the growth of the Infusion Pump Market. The Infusion pump market size to witness significant growth due to growth in the burgeoning healthcare sector and increasing occurrences of fatal & chronic diseases, globally. Moreover, rising awareness and concerns related to health are some of the factors escalating the market at a global level.

 

Nevertheless, advanced infusion systems would support market growth, increasingly allowing hospitals to make the most of the required expertise. These improved systems would also enable greater participation throughout the infusion process. As medical records become more automated, infusion pumps are too expected to grow increasingly automated. Moreover, as electronic medical records and smart pumps penetrate deeply into the developed markets such as the US and Europe, the infusion pump market value is expected to increase further.

 

 Global Infusion Pump Market Segmentation

The global infusion pump market has been segmented based on

  • Types
  • Application
  • End-user
  • Regions

Based on Types, the global market has been segmented into

  • Volumetric Pump
  • Syringe Pump
  • Ambulatory Pump
  • others

Based on Application, the global market has been segmented into

  • Chemotherapy
  • Diabetes
  • Gastrointestinal Diseases
  • Pediatrics
  • Other

Based on End-user, the global market has been segmented into

  • Hospitals
  • Ambulatory Surgical Centers
  • Homecare
  • Others

Infusion Pump Market Regional Analysis

Based on the geographical distribution, the Global infusion pump market is split among the regions of

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa

North America infusion pump market size is expected to reach USD 3.49 Billion by 2023. North America leads the largest infusion pump market share globally. In the region, advancements in technologies are continuously on the rise. Besides, the high prevalence of diabetes and high healthcare expenditures are fostering regional market growth. The US and Canada, heading with a large number of diabetic population and increasing aging population account for the growth contributors to the regional market. Additionally, the presence of well-established healthcare sector and key players substantiate the growth of the regional market.  Rising with the augmenting market demand,

The European infusion pump market share would reach nearly USD 3.11 billion by the end of the forecast period.  The infusion pump market in the European region is another lucrative market on the global platform. Increasing uptake of infusion pumps for the treatments of rising numbers of diabetic population and focus on using stem cell-derived human islets as a possible cure for type 1 diabetes, drive the regional market growth, commutatively. Besides, availability of funds from the public and private bodies to drive the research and development activities in biotechnology are expected to boost the market growth in the region.

The Asia Pacific infusion pump market size is estimated to register a CAGR of 5.4% throughout the assessment period (2017-2023). The region Factors, such as the presence of proliferating healthcare sector and the improving economy and disposable income per individual are substantiating the growth of the regional market.

Global Infusion Pump Market Competitive Landscape:

Fiercely competitive, the infusion pump market appears to be highly fragmented, characterized by the presence of several well-established players. These players increasingly seek a substantially large revenue and market expansion through various strategic initiatives, such as mergers & acquisitions, collaboration, and product launch. They also invest colossally in research & development activities to innovate and develop a cost-effective product portfolio.

Players operating in the infusion pump markets are increasingly focusing on optimizing situational awareness for customers to ensure their mission success. They possess state-of-art developing labs and strong sales & distribution network, which can help them to gain a leadership position in the market.

Major Players:

Players leading the global infusion pump market, include B. BRAUN MELSUNGEN AG, 3M, Baxter, Fresenius Kabi AG, Becton, Dickinson and Company, ICU Medical, Inc, Terumo Medical Corporation, Zyno Medical and Smiths Medical, among others.

Drivers and Impact:

  • Growing Demand from Key Applications and Potential Industries
  • Rising Demand from Key Regions
  • Intensity of Rivalry
  • Infusion Pump Market Challenges and Impact
  • Infusion Pump Market Trends and Key Opportunities

Browse Full Research Report At: https://www.marketresearchfuture.com/reports/infusion-pumps-market-1509

Industry/ Innovation/ Related News

August 29, 2019 – Eitan Group (Israel), a global leader in advanced infusion therapy solutions across the care continuum, announced its partnership with InfuSystem Holdings, Inc. (INFU – the US), a leading provider of infusion pumps & related services for the healthcare industry in North America. The companies would work together to offer improved repair services to Eitan Group’s suite of infusion systems, including its flagship Sapphire infusion system. The partnership deal is expected to significantly shorten the time it takes to repair Sapphire Infusion Pumps while reducing costs to the end-user at the same time.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services.

 https://www.marketresearchfuture.com

]]>
Leprosy Treatment Market Analysis Devices, By Top Key Players, Global Industry Size, Growth Opportunity, Latest Trends and Advanced Technologies To 2023 Sat, 28 Mar 2020 04:04:22 +0100 http://comunicati.net/comunicati/aziende/tecnologia/626508.html http://comunicati.net/comunicati/aziende/tecnologia/626508.html Market Research Future Market Research Future Leprosy Treatment Market– Overview

Leprosy is one of the diseases that had transformed societies following its outbreak, but after major efforts to eradicate this disease, the detection rates have fallen immensely. Market reports connected with the healthcare industry have been made available by Market Research Future which generates reports on other business verticals that outlines the current market scenarios. The Leprosy Treatment Marketis expected to achieve $ 3.5 billion while progressing at a CAGR of 3.2 % through the forecast period.

The stigma related to the disease had caused significant hurdles in the treatment of leprosy, but a better awareness of the symptoms of the disease has led to the development of the market. Improved detection techniques are expected to further aid the development of the market in the forecast period.

  Leprosy Treatment Market – Key Players: 

The competitors shaping the leprosy treatment market are –

Systopic Laboratories Pvt. Ltd.

Cadila Pharmaceuticals

Novartis International AG

Acme Pharmaceuticals

Macleods Pharmaceuticals

Glaxo SmithKline

Astra Zeneca

Lark Laboratories Ltd. `

Segmental Analysis

The leprosy treatment market is segmented on the basis of disease type, drug class, and market channel. On the basis of drug class, the leprosy treatment market has been segmented into phenazine, sulfone, derivative, anti-tubercular drugs and others. On the basis of disease type, the market has been segmented into multibacillary leprosy and paucibacillary leprosy. On the basis of end users, the market has been segmented into contract, private, and others. The regions included in the market segmentation are Middle East, North America, Asia Pacific, Europe, Africa and the rest of the world.

Detailed Regional Analysis

The regional analysis of the leprosy treatment market covers regions such as the Middle East, North America, Asia Pacific, Europe, Africa and rest of the world. In the North American region, the US is responsible for the maximum market share owing to the favorable reimbursement scenario and increased expenditure on healthcare. The rapid market uptake of new technology in the US is also an essential driver of the market for leprosy treatment. The European region is the next biggest market owing to the availability of large disposable income and improving awareness. The Asia Pacific region is anticipated to have the most potential and it is expected to be led by nations such as China and India. The Middle East & Africa market is controlled by the Gulf nations especially Saudi Arabia and UAE. The poor regions of Africa are anticipated to witness restricted growth due to slow economic and political conditions and restricted healthcare penetration.

Competitive Analysis

The use of effective strategy execution techniques is expected to bear optimistically on the future growth of the Leprosy Treatment Market. The competitors in the market are attempting to establish various leaderships that will enable them to capture a more significant share of the market. Improved accessibility to diverse resources and capabilities is expected to impel the growth of the market in the coming forecast period. Moreover, the vertical integrations and product strategies of the market is increasing the prospects for the market players. The analysis of the market reveals that it is poised for a high growth rate in the forthcoming years. Product differentiation has created a favorable product differentiation scenario that is complementing the market’s growth.

get full report @ https://www.marketresearchfuture.com/reports/leprosy-treatment-market-3862

Industry Updates

Mar 2018 In a recent study by Flavio Alves Lara of the Oswaldo Cruz Institute and colleagues has for the first time characterized blood clots that help in detecting leprosy at an early stage. Their findings lead to a new understanding of how leprosy affects the circulatory system but also to possible new screening tests to detect leprosy sooner. Lara and colleagues had searched for blood clotting abnormalities among 638 leprosy patients and identified 35 patients who had uncommon fatty clots, which the researchers named “leprosum clots.” The team studied what factors could signal the development of these clots and what molecules were existing in them.

Related Reports: 

Infusion Pump Market 

Halitosis Treatment Market 

 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

https://www.marketresearchfuture.com

]]>
Laser Therapy Market Research Report, By Type (Diode Lasers, Solid State Lasers, Gas Lasers, Dye Lasers, and others), By Application (Dermatology and Aesthetics, Surgery, Dental, Urology, Ophthalmology, and others) — Global Forecast from 2017 to 2023 Market Research Future (MRFR) anticipates strong CAGR of 9.2% in the global laser therapy market over the forecast period of 2017–2023. The expansion of the global laser therapy is the result of various market dynamics, out of which, the surging Sat, 28 Mar 2020 03:47:23 +0100 http://comunicati.net/comunicati/aziende/tecnologia/626507.html http://comunicati.net/comunicati/aziende/tecnologia/626507.html Market Research Future Market Research Future Laser Therapy Market Research Report, By Type (Diode Lasers, Solid State Lasers, Gas Lasers, Dye Lasers, and others), By Application (Dermatology and Aesthetics, Surgery, Dental, Urology, Ophthalmology, and others) — Global Forecast from 2017 to 2023

Market Research Future (MRFR) anticipates strong CAGR of 9.2% in the global laser therapy market over the forecast period of 2017–2023. The expansion of the global laser therapy is the result of various market dynamics, out of which, the surging prevalence of diseases such as cataract and arthritis bears profound weightage. Laser therapy is the standard line of treatment in cases of cataract. Laser-based ophthalmology is highly preferred over other methods of treatment. YAG LASER, excimer LASER, femtosecond LASER, and others are the most commonly used lasers in ophthalmology. The widespread prevalence of cataract, as well as arthritis, promote the growth of the global laser therapy market. Expanding base of old population complements this factor since the elderly populace is more prone to acquiring diseases such as arthritis and cataract which induces additional demand for laser therapy. Heightened demand for minimally-invasive and non-invasive procedures is a major drive behind the growth of the market. Consumers are highly inclined towards medical procedures which do not involve incisions and cuts. Additionally, laser therapy is extensively used in dermatology and cosmetology. Skyrocketing demand for aesthetics also encourages the growth of the global laser therapy market. Use of laser therapy in dentistry is also a key market influencer. On the contrary, the growth of the global laser therapy market might be impeded by high costs associated with laser therapy.

Segmentation

The global laser therapy market has been segmented based on type and application.

By type, the global laser therapy market has been segmented into diode lasers, solid state lasers, gas lasers, dye lasers, and others.

By application, the global laser therapy market has been segmented into surgery, dermatology and aesthetics, dental, and others. The surgery segment is further segmented into urology, ophthalmology, and others.

Regional Analysis

The Americas, Asia Pacific (APAC), Europe, and The Middle East & Africa (MEA) are the key markets for laser therapy.

The Americas is at the forefront of the global laser therapy market. A robust healthcare sector, high expenditure on healthcare, and widespread prevalence of chronic diseases in the region spur the growth of the global laser therapy market. In addition, the regions propensity to incorporate new and advanced technologies in the healthcare sector acts as a plus for the growth of the market. Other factors boosting the growth of the Americas market include growth in a number of aged populace and the presence of key players in the region.

Europe holds the second most significant share of the global laser therapy market. The region invests substantially in R&D activities which coupled with the availability of funds creates a conducive environment for the growth of the laser therapy market in Europe. A broad base of the patient population, well-developed healthcare sector, and high government support contribute to the growth of the market.

APAC is the fastest growing market for laser therapy. Expanding patient pool, development of the healthcare sector in the developing countries of China and India present growth opportunities to the APAC market. Also, increased affordability due to rising disposable income, government endeavors towards the modernization of the healthcare sector are other boosting factors.

The MEA market is likely to exhibit the least share of the global laser therapy market. Limited availability of healthcare facilities, lack of funds, and lack of awareness and dearth of skilled medical professionals constrain the growth of the market over the forecast period, especially in the Africa region. The Middle East accounts for the foremost share of the MEA market and is driven by high healthcare expenditure in the region.

Access Report Details @ https://www.marketresearchfuture.com/reports/laser-therapy-market-3812

Competitive Landscape

The key players in the global laser therapy market include Biolase Inc. (U.S.), Alma Lasers (Israel), Cutera (U.S.), IRIDEX Corp. (U.S.), Valeant (Canada), Coherent, Inc. (U.S.), and Angiodynamics, Inc. (U.S.).

Industry Updates

In December 2018, TRUMPF GmbH, a company involved in laser technology, announced the acquisition of Photonics GmbH from Philips. Through the acquisition, TRUMPF intends to expand its foothold in the growing markets in the photonics and digital products sectors.

Related news

Medical Tourism Market
Immunoassay Analyzers Market Share

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact

https://www.marketresearchfuture.com

]]>
Optical Coherence Tomography Market | Worldwide Overview by Size, Share, Trends, Segments, Leading Players, Demand and Supply with Regional Forecast - 2023 Sat, 28 Mar 2020 03:36:08 +0100 http://comunicati.net/comunicati/aziende/tecnologia/626506.html http://comunicati.net/comunicati/aziende/tecnologia/626506.html Market Research Future Market Research Future Global Optical Coherence Tomography (OCT) Market Size, Trends and Share Analysis By Technology (Sd-Oct, Swept-Source Oct), Application (Cardiology, Ophthalmology, Dermatology, Others), Type Of Devices (Handheld, Tabletop, Catheter-Based Oct Devices), Key Players and Region, Forecast to 2023

 

Augmenting demand for advanced devices that can provide a faster diagnosis with higher accuracy and advancements in optical coherence tomography are some of the key driving forces pushing the Optical Coherence Tomography Market growth.

Additionally, factors such as the ongoing product development & commercialization led by the favourable reimbursement policies and rising number of approvals from regulatory bodies are boosting the optical coherence tomography market growth. Moreover, increasing the adoption of OCT as one of the most critical imaging techniques in various medical applications is contributing to the growth of the optical coherence tomography market.

 

On the flip side, the high cost and the scepticism of physicians towards the advancement & efficacies of OCT devices inhibit the optical coherence tomography market growth. Also, the need for physician's training is a significant factor expected to obstruct the market growth during the assessment period. Nevertheless, efforts & investments transpired into the R&D activities by the key market players would support the growth of the market, bringing about cost-effective solutions.

Optical Coherence Tomography Market Segmentation:


Application
Type of Devices

 

Based on Technology, the optical coherence tomography market is segmented into

Swept-Source OCT
Spectral-Domain OCT (SD-OCT)
others

 

Based on Application Optical Coherence Tomography (OCT) market is segmented into

Ophthalmology
Dermatology
Cardiology
others

 

Based on Type of Devices Optical Coherence Tomography (OCT) market is segmented into

Table-top
Handheld
Catheter-based OCT Devices
others

 

Optical Coherence Tomography Market Geographical Analysis:

 

North America is projected to retain its leading position in the global optical coherence tomography market throughout the forecast period. The presence of a large diabetic patient population substantiates the regional market growth, augmenting the demand for diabetic retinopathy. Besides, neurovascular and other eye-related diseases are supporting the growth of the regional market.

 

Additional factors such as the rising demand for minimally invasive and technologically advanced treatments, alongside the tremendous government support and high healthcare expenditures, foster the regional market growth. Furthermore, the presence of the growing number of diabetic patients and leading players propels the regional market.

The European optical coherence tomography market stands second on a global level. Factors boosting the regional market growth include the presence of well-established healthcare sectors and the growing number of advanced treatment facilities in the region. Moreover, the increasing demand for better healthcare infrastructure, led by the rising prevalence of diabetes and increasing per-capita healthcare expenses, drive enormous market demand.

 

The optical coherence tomography market in the Asia Pacific region is emerging as a lucrative market, globally, witnessing increased funding support from the private and public sectors. Moreover, increasing R&D activities and the rising number of diabetic retinopathy & other eye diseases are some of the key factors fostering regional market growth. Furthermore, increasing access to new treatment methods is expected to support the APAC OCT market, increasingly meeting the growing demand for treatments of prevailing optical diseases.

 

Optical Coherence Tomography (OCT) Market Competitive Analysis:

 

Fiercely competitive, the optical coherence tomography (OCT) market appears to be fragmented due to the presence of several well-established players. To gain a substantially larger share in the market, players incorporate strategic initiatives such as mergers & acquisitions, collaborations, expansion, and new therapeutics & technology launch. High potential growth opportunities demonstrated by the market attract several new entrants, which further intensifies the market competition. Players also substantially invest in R&D to develop advanced technologies and devices with unique features.

 

Optical Coherence Tomography Market Major Players:

 

Players leading the global optical coherence tomography (OCT) market are Abbott Laboratories, Alcon, Carl Zeiss AG, Terumo Corporation, Koninklijke Philips N.V, B. Braun Melsungen AG, Boston Scientific Corporation, Topcon Corporation, NIDEK Co., Ltd, Novacam Technologies Inc., OPTOPOL Technology S.A, Heidelberg Engineering GmbH, Imalux Corporation, Michelson Diagnostics, Agfa Healthcare, and Thorlabs Inc. among others.

 

Industry/Innovation/Related News:

 

Canon U.S.A., Inc., a leading provider of digital imaging solutions, announced that its new intuitive, user-friendly Xephilio OCT-A1 Optical Coherence Tomography device has received FDA 510(k) clearance for sale in the US. The Xephilio OCT-A1 features automated acquisition functionality, which allows obtaining high-quality, reproducible scans and images.

 

Canon's optical coherence tomography device is indicated for the in-vivo imaging and measurement of the retina, retinal nerve fiber layer, and optic disc. Besides, the Xephilio OCT-A1 System can identify the disease state and monitor disease conditions before and after treatments in private ophthalmology practices, retinal clinics, teaching hospitals, and institutions.

 

The versatile OCT device can be used in a variety of settings, including telehealth and telemedicine primary care providers. For optometry practices and optometric schools, this System can aid in recognizing diseases & conditions in primary care.

 

Browse Full Research Report

At https://www.marketresearchfuture.com/reports/optical-coherence-tomography-market-1328

 

Related News

 

DNA Sequencing Market

Vein illuminator Market

 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.

]]>
Zika Virus Testing Market Product Scope Global Trend and Industry Share Analysis Sat, 28 Mar 2020 03:25:44 +0100 http://comunicati.net/comunicati/aziende/tecnologia/626505.html http://comunicati.net/comunicati/aziende/tecnologia/626505.html Market Research Future Market Research Future Zika Virus Testing Market is anticipated to be driven by increasing Zika incidences around the globe. This virus was first detected in Rhesus monkeys in Uganda in 1947. Then, in 1952, humans were detected with the virus.

The “Zika Virus Testing Market” In-Depth competition analysis of the major companies in the report, sector of the report includes the market depictions, requirements, and product portrayals, manufacture, competence, contact figures, cost, and revenue.

The Zika Virus Testing Market Free Growth Sample will provide valuable insight with an emphasis on the global market including some of the major players such As, ARUP Laboratories, Hologic, Luminex Corporation, Roche Molecular Systems, etc.

Various application sub-segments of the industry comprise hospitals, ambulatory centers, pathology laboratories, diagnostic centers, etc. The different screening tests include nucleic acid amplification and Zika virus antibody. Based on geographies, the market is classified on the basis of Europe, Asia Pacific, Americas, and the Middle East and Africa.

The steady transfer of Zika in Americas has led to the demand for effective screening services till the end of the forecast period. The continuous demand for the better identification & management of this illness should propel industry sales.

Zika Virus Testing Market Segment by Regions, regional analysis covers:

  • North America(United States, Canada and Mexico)
  • Europe(Germany, France, UK, Russia and Italy)
  • Asia-Pacific(China, Japan, Korea, India and Southeast Asia)
  • South America(Brazil, Argentina, Colombia etc.)
  • Middle East and Africa(Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Reasons to Purchase this Report

  • Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
  • Provision of market value (USD Billion) data for each segment and sub-segment
  • Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
  • Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
  • The competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled

Access Complete Detailed TOC Research Report at https://www.marketresearchfuture.com/reports/zika-virus-testing-market-5662

For Market Zika Virus Testing Market analysis, the report covers upstream raw materials, equipment, downstream client survey, Marketing channels, Market development trend and proposals, which more specifically include valuable information By key applications and consumption, key regions and consumption, key Global distributors , major raw materials suppliers and contact information, major manufacturing equipment suppliers and contact information, major suppliers and contact Information, key consumers and contact information, and supply.

About Market Research Future: MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

]]>
mHealth Applications Market Growth 2020, Innovation, Increasing Digitalization, Dynamics, Specification, Business Opportunities by Forecast 2022 Sat, 28 Mar 2020 03:16:34 +0100 http://comunicati.net/comunicati/aziende/tecnologia/626504.html http://comunicati.net/comunicati/aziende/tecnologia/626504.html Market Research Future Market Research Future mHealth Market Information, By Therapeutics(respiratory, mental and neurological disorders, fitness & lifestyle) By Application(monitoring, diagnosis & treatment, wellness & prevention) – Forecast to 2022

Leading Market Players

Allscripts, Agamatrix, Inc., Medtronic MiniMed, Inc., Honeywell International Inc., Vivify Health, iHealth Labs Inc., and Apple Inc. are some of the key players operational in the global mHealth applications market.

Overview:

The global market for mHealth applications is depending on a thrust that can be provided by the IT sector in the coming years. The growth, as discussed by Market Research Future (MRFR), can reach a valuation of USD 100.2 Bn by 2023. MRFR considers 2016 to 2023 as the forecast period where the growth for the market would be substantial. Growing demand for mHealth is winning traction from sectors like transforming face of the traditional medical practices, creation of the path for better healthcare in the future, and others. Growing inclusion of better internet facilities, Bluetooth, and Wi-fi can inspire better growth for the market.

Segmentation Analysis

The global mHealth applications market report is segmented by type.

By drug type, it is segmented into wellness & prevention, education & awareness, diagnosis & treatment, monitoring applications, and healthcare management. Monitoring applications held close to 53.8% market share in 2016. This can be attributed to alarming levels of diabetes, obesity, and cardiovascular diseases which need to be controlled. In addition, demand for disease management in rural areas can drive the segment growth in the coming years.

Regional Analysis

North America, Asia Pacific (APAC), Europe, and the Rest-of-the-World (RoW) are the regions being considered for the basis of the report.

Europe has the lead in the global mHealth applications market owing to efforts taken by various healthcare developers in extending the research of chronic diseases. Prevalence of rare diseases as well as the capacity of wearables to record information assisted pharma companies in improving their outcomes at a rapid pace.

The APAC region is the second-largest in terms of revenue in the market. This can be attributed to consolidation among hospital chains as well as efforts to lower patient burden on hospital staff. In addition, policies for digitization of hospital data and approval of mHealth applications by doctors and physicians can bolster the market growth. The region can exhibit 33.7% CAGR during the forecast period.

TABLE OF CONTENT

3 MARKET OVERVIEW

3.1 INTRODUCTION

3.2 MARKET DYNAMICS

3.2.1 MARKET DRIVERS

3.2.1.1 Patients Involvement In Personal Healthcare

3.2.1.2 Proliferation Of Smartphones And Wearable Devices Into Healthcare

3.2.1.3 Integration Of Wireless Technologies With Portable Healthcare Devices

3.2.1.4 Introduction Of Connected Healthcare Solutions In The MHealth Market

3.2.1.5 Benefits Of Cost Effectiveness And Patients’ Convenience

3.2.1.6 Increase In Lifestyle Disease

3.2.2 MARKET CHALLENGES

3.2.2.1 Low Rate Of Literacy And Language Barriers In Low- And Middle-Income Countries (LMICs)

3.2.2.2 Invasion Of Privacy

3.2.2.2.1 Security Breach Cases

3.2.2.2.2 Potential Risk Of Hardware Or Software Failure

3.2.2.2.3 Stringent Regulations And Standards

3.2.2.2.4 Lack Of Awareness About The Possible Applications Of MHealth

3.2.3 MARKET OPPORTUNITIES

3.2.3.1 Partnership: An Entry Mode

3.2.3.2 Introduction Of MHealth In Developing Economies

CONTINUED..

COLLECT DETAILED REPORT INFORMATION @ https://www.marketresearchfuture.com/reports/mobile-health-market-1816

June 2019: University of Washington’s researchers are coming up with a mHealth app which will integrate with various digital platforms such as Google Home or Amazon Alexa and monitor the breathing patterns of a user during sleep for the evidence of a cardiac arrest. This digital health tool will use artificial intelligence technology.

RELATED TRENDING REPORTS

Prostate cancer Market

 Infusion Pump Market

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

]]>
Artificial Neural Network Market Size 2020, Industry Growth, Size, Company Profiles, Regional Study, Business Trends, Landscape and Demand with Forecast 2023 Sat, 28 Mar 2020 03:02:13 +0100 http://comunicati.net/comunicati/aziende/tecnologia/626503.html http://comunicati.net/comunicati/aziende/tecnologia/626503.html Market Research Future Market Research Future Global Artificial Neural Network Market Research Report: By Type (Feedback Artificial Neural Network, Feedforward Artificial Neural Network, Other), by Component (Software, Services, Other), by Application (Drug Development, Others) – Forecast Till 2023

Leading Market Players

Key players profiled in the artificial neural network market include Oracle Corporation, IBM Corporation, Microsoft Corporation, Intel Corporation, Qualcomm Technologies, Inc., Neuralware, Google Inc., Alyuda Research, LLC., NeuroDimension, Inc., SAP SE, Ward Systems Group, Inc., Afiniti, SwiftKey, Neural Technologies Limited, and Starmind International AG.

Market Overview

The global artificial neural network market is expected to exhibit a stellar growth rate from 2018 to 2023 (forecast period). Emergence of ANN in healthcare and finance sectors are predicted to drive the market growth. Increasing prevalence of chronic diseases, growing number of admissions in hospitals, and inflated healthcare expenditure of nations are other drivers supporting the adoption of ANN in healthcare. Development of software to support the large patient volume can drive the market growth. For instance, the MAQ software by Microsoft Corporation contains an ANN to predict future trends.

Segmentation

The artificial neural network market is segmented by type, component, and application.

By type, it is segmented into feedback artificial neural network, feedforward artificial neural network, and others. The feedforward artificial neural network segment is expected to reign supreme over the forecast period due to immense demand for advanced analytical systems.

By component, it is segmented into software, services, and platform.

By application, it is segmented into drug development, image analysis and interpretation, bioelectric signal analysis and interpretation, clinical diagnosis and prognostics, and others. The image analysis application is projected to possess future potential due to the use of deep learning algorithms for identifying faces in massive crowds. This is highly useful for law enforcement agencies in thwarting potential attacks.

Regional Analysis

Regionally, the artificial neural network market covers the Americas, Asia Pacific (APAC), Europe, and the Middle East & Africa.

The Americas is anticipated to be the dominant region in the global market due to large number of enterprises for development of neural network technologies and well-developed healthcare sector. The large healthcare expenditure for the region is likely to bode well for the market growth. Emergence of self-driving or autonomous driving has gained the interest of various manufacturers in the technology. Artificial neurons can be used in analyzing driver behavior on the roads. This has become useful for Tesla, one of the biggest advocates of self-driving cars, in developing its Self Driving Computer.

Europe is assumed to be in the second position in the global market due to inflated healthcare expenditure and adoption of AI among healthcare providers. The ballooned defense expenditure of nations is likely to fuel the adoption of ANN and deep learning to further the development of autonomous systems to strengthen existing defenses. On the other hand, the APAC region is presumed to exhibit the fastest growth rate during the forecast period due to need to control healthcare costs and rising economic growth of countries. Digitization of patient records is expected to influence the market growth.

Table Of Contents:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Continued…

Collect detailed report @ https://www.marketresearchfuture.com/reports/artificial-neural-network-market-6287

In August 2019, Google researchers launched the new Weight Agnostic Neural Networks that would perform without assessing the weight first. This would help in devising programs that would require no training.

Related Trending Healthcare Reports

mHealth Applications Market

 

Mucormycosis Market

 

About Market Research Future:

MRFR team has supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country-level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with the technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

]]>
Global Smart Helmet Market Size, Share, Growth, Trends and Industry Analysis Report, 2019 to 2025 Fri, 27 Mar 2020 19:13:57 +0100 http://comunicati.net/comunicati/aziende/tecnologia/626497.html http://comunicati.net/comunicati/aziende/tecnologia/626497.html Grand View Research Grand View Research The global smart helmet market size is expected to reach USD 1.20 billion by 2025, expanding at a CAGR of 18.6% from 2019 to 2025, according to a new study by Grand View Research, Inc. Rising popularity of the product in various applications such as riding, adventure sports, manufacturing, and construction is projected to drive the growth.

These protective headgears provide users with enhanced safety, security, and comfort. The growing adoption of smart wearable technology, stringent workplace safety and road safety regulations laid down by governments, and increasing awareness for personal health and safety are expected to drive the demand for smart helmets over the forecast period.

Smart helmets consist of multiple sensors that perform functions such as heart rate monitoring, temperature monitoring, and air quality monitoring. The sensors collect data in real time to provide users with detailed information regarding various interactions, navigation, and environmental and health attributes.

Satellite aided navigation is one of the most vital features offered by smart helmets. It enables highly accurate navigation capability by using multiple satellite networks such as Global Navigation Satellite System (GLONASS), Global Positioning System (GPS), Galileo Positioning System, BeiDou Navigation Satellite System, and Indian Regional Navigation Satellite System (IRNSS).

Smart helmets are further capable of providing a wide range of other communication, utility, and safety features using built-in speakers, microphones, rear-facing cameras, cooling fans, solar chargers, and health monitoring sensors. Manufacturers are using materials that are light in weight and high in strength, such as fiberglass reinforced plastic and carbon fiber, for weight reduction and enhanced survivability.

Increasing adoption of next-generation technologies such as Augmented Reality (AR), Virtual Reality (VR), and Artificial Intelligence (AI) is anticipated to drive the development and adoption of smart helmets. Factors such as emerging road safety regulations, development of wireless communication infrastructure, large-scale production of motorcycles, and increasing disposable income are expected to drive the growth of smart helmets industry in emerging countries such as India, Brazil, and China.

Further key findings from the study suggest:

  • Navigation segment is expected to emerge as the fastest-growing segment over the forecast period owing to the increasing adoption of smart helmets by bike riders for in-country and cross-country navigation
  • Full face segment is expected to expand at the highest CAGR of 18.8% over the forecast period. Increased adoption of full-face smart helmets by motorcycle and cycle commuters due to superior safety features is expected to drive the growth
  • Asia Pacific is anticipated to emerge as the fastest-growing regional market over the forecast period owing to the increasing sales of two-wheelers and rapidly growing industrial and construction projects
  • Consumer end use segment is expected to gain traction over the forecast period owing to increasing adoption of smart helmets in developed regions such as North America and Europe. Due to increased road traffic, 2-wheelers are now being favored as the preferred mode of commute, which is expected to act as a major growth driver
  • Key players operating in the smart helmets market include Nand Logic Corp.; Lifebeam Technologies Ltd.; Forcite Helmet System Pvt. Ltd.; Fusar Technologies Inc.; 360fly Inc.; Daqri LLC; Jarvish Inc.; Sena Technologies Inc.; Babaali; and Jager HelmX Smart Helmets

Grand View Research has segmented the global smart helmets market based on type, component, end use, and region:

Smart Helmet Type Outlook (Revenue, USD Million, 2017 - 2025)

  • Full Face
  • Half Face
  • Hard Hat

Smart Helmet Component Outlook (Revenue, USD Million, 2017 - 2025)

  • Communication
  • Navigation
  • Camera
  • Others

Smart Helmet End Use Outlook (Revenue, USD Million, 2017 - 2025)

  • Consumer
  • Manufacturing
  • Construction
  • Others

Smart Helmet Regional Outlook (Revenue, USD Million, 2017 - 2025)

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
  • Asia Pacific
    • China
    • India
    • Japan
  • Latin America
    • Brazil
  • Middle East & Africa

Access full research report on global smart helmet market:
www.grandviewresearch.com/industry-analysis/smart-helmet-market

]]>
Il ruolo della giurisprudenza nella creazione del diritto: Nicolò Zanon interviene come relatore a Pisa Fri, 27 Mar 2020 18:50:43 +0100 http://comunicati.net/comunicati/aziende/varie/626495.html http://comunicati.net/comunicati/aziende/varie/626495.html nzprnews nzprnews Moderato dal Consigliere della Corte di Cassazione Giuseppe Pavich, il dibattito tenutosi il 14 febbraio presso l'Università di Pisa è stato incentrato sul contributo della giurisprudenza nella formazione e nell'evoluzione del diritto. Tra i relatori intervenuti, Nicolò Zanon, Giudice della Corte Costituzionale, e Giovanni Canzio, già primo Presidente della Corte di Cassazione.

Nicolò Zanon

Nicolò Zanon all'evento dedicato al diritto giurisprudenziale

Il Giudice della Corte Costituzionale e Professore Ordinario di Diritto Costituzionale Nicolò Zanon ha preso parte al seminario dal titolo Il Diritto Giurisprudenziale. Le Corti tra applicazione e creazione del diritto, svoltosi venerdì 14 febbraio in occasione dell'inaugurazione del nuovo anno della Scuola di Specializzazione per le professioni legali. Nella cornice dello storico Palazzo della Sapienza, sede principale della Facoltà di Giurisprudenza dell'Università di Pisa, il dibattito ha avuto come tema principale la natura del diritto di origine giurisprudenziale, alla luce del ruolo svolto dalla giurisprudenza all'interno del processo di formazione ed evoluzione del diritto. Tale apporto, nel corso degli ultimi decenni, ha assunto una consistenza e una rilevanza sempre maggiore, come evidenziato dal Giudice della Corte Costituzionale Nicolò Zanon nel corso del dibattito svolto insieme al Primo Presidente emerito della Corte di Cassazione, Giovanni Canzio. Il dibattito ha messo in luce potenzialità e limiti dell'apporto della giurisprudenza alla creazione del diritto.

L'impegno accademico e gli incarichi giuridici di Nicolò Zanon

Nato a Torino nel 1961, Nicolò Zanon è Giudice della Corte costituzionale dal 2014 e Professore Ordinario di Diritto costituzionale presso l'Università degli Studi di Milano. Dopo aver ottenuto la laurea in Giurisprudenza con una tesi in Diritto Pubblico Comparato presso l'Università di Torino, ha conseguito il titolo di Dottore in Ricerca in Diritto Comparato all'Università di Firenze. Il suo percorso in ambito accademico ha inizio nel 1991, quale ricercatore presso la Facoltà di Scienze Politiche di Torino. In seguito, è professore a contratto di Istituzioni di Diritto Pubblico presso l'Università Bocconi di Milano. Tra il 1996 e il 1997, presso la Corte Costituzionale, è Assistente di Studio del Giudice Costituzionale Valerio Onida. La sua carriera prosegue con la nomina, nel 1998, a componente del "Gruppo di lavoro per la Riforma dello Statuto regionale". Nel 1996 e nel 1997, Nicolò Zanon è Professore Associato presso l'Università di Padova, poi Professore Associato presso l'Università di Milano-Bicocca e infine Straordinario e Ordinario presso l'Università degli Studi di Milano. A partire dal 2000, per dieci anni, è stato membro del Comitato Legislativo della Regione Lombardia. La sua carriera istituzionale lo conduce, nel 2009, a essere eletto dal Senato della Repubblica quale membro del Consiglio di Presidenza della Giustizia Amministrativa. Nel 2010, viene eletto dal Parlamento in seduta comune componente laico del Consiglio Superiore della Magistratura. Conclude questo mandato nel 2014, anno in cui viene nominato Giudice della Corte Costituzionale dal Presidente della Repubblica Giorgio Napolitano. Nel 2017 è stato insignito del titolo di Cavaliere di gran croce dell'Ordine al merito della Repubblica italiana.

]]>
Ink Solvent Industry - Size, Share, Growth, Trends, and Regional Outlook by 2023 Fri, 27 Mar 2020 18:10:20 +0100 http://comunicati.net/comunicati/aziende/informatica/information_technology/626493.html http://comunicati.net/comunicati/aziende/informatica/information_technology/626493.html Market Research Future Market Research Future Market Research Future Published a Half-Cooked Research Report on Ink Solvent Market Research Report- Forecast to 2023

Market Definition:

Ink solvent finds strong commercial, household and industrial printing application. Some of the popular variants of ink solvent are ethyl acetate, n-propyl acetate, methylated spirits and isopropanol. Market Research Future (MRFR) projects that the global Ink solvent market will witness a healthy growth over the next couple of years.

Get a Free Sample @ https://www.marketresearchfuture.com/sample_request/5123

Market Overview and Growth Factors:

High efficiency, cost-effectiveness, high evaporation rate and impressive non-coating properties make ink solvent a sought-after industrial material. Ink solvent has quickly replaced other conventional alternatives. Ink solvent cater to requirements such as corrosion resistance and low surface tension.

In the coming years, demand for eco-friendly and bio-based variants is expected to grow significantly. Rising concern over co2 emission and toxic growth is prompting industries to shift towards options that are environmentally viable. Bio-based variants support recyclability, high boiling point and low miscibility. More and more companies are shifting focus towards eco-friendly solvents. These variants are quickly gaining traction in end-use industries like construction and paints and coatings.

Competition Analysis:

  • Arkema S.A. (France),
  • Celanese Corporation (U.S.),
  • Eastman Chemical Company (U.S.),
  • INEOS (U.K.),
  • Royal Dutch Shell plc (the Netherlands),
  • Ashland (U.S.),
  • The Dow Chemical Company (U.S.),
  • BASF SE (Germany),
  • OMNOVA Solutions Inc (U.S.)
  • Evonik Industries AG (Germany)

Global Ink Solvent Market: Segmental Analysis

MRFR’s report includes a detailed segmental analysis of the market based on chemistry type, process, product type and application.

Based on chemisty type, the Ink Solvent Market Trends  has been segmented into hydrocarbons, acetates and alcohols. On the basis of process, the market has been segmented into gravure and flexographic. The flexographic segment accounts for the largest market share in terms of revenue. This is mainly owing to inexpensiveness, reusability, and widespread availabity of flexographic.

On the basis of product type, the market has been segmented into green, bio-based and conventional. On the basis of application, the market has been segmented into publication, corrugates, packaging and others. The packaging segment represent the largest market share. High demand for ink solvent in magazines, periodicals, flexible films, directories, catalogs, etc. is driving the growth of the market. During the forecast period, the segment is expected to register an impressive growth owing to the tremendous expansion of the flexible packaging industry.

Browse key industry insights spread across 138 pages with 59market data tables & 15 figures & charts from the report, “Ink Solvent Market Research Report by Chemistry Type (Alcohols, Acetates, Hydrocarbons), by Product Type (Conventional, Green & Bio-Based), by Process (Flexographic Gravure), by Application (Packaging, Corrugated, Publication) – Forecast till 2023” in detail along with the table of contents @

https://www.marketresearchfuture.com/reports/ink-solvent-market-5123

Regional Analysis:

The market has been covered across regions such as North America, Asia Pacific (APAC), Europe, the Middle East & Africa (MEA) and Latin America. Of these, the market looks brightest in APAC. The growing demand for Ink solvent in corrugated, packaging, publication, among others is supporting the market growth in APAC. The growth of the packaging sector owing to increased demand for packaged food, and other commercially produced items in APAC countries is creation attractive market opportunities. Moreover, increased R&D activities in end-use verticals has reflected favourably on the uptake of the product. In APAC, countries such as India, Japan and China are likely to emerge as major contributors to the market in terms of revenue.

The market is also flourishing in North America. Presence of established end-use verticals in countries such as the U.S. and Canada remains a favourable proposition for market players operating in the region. In addition, increased efforts to bolster the end-use sectors in the region is likely to create lucrative market opportunities in the coming years. In North America, the spotlight is expected to remain is countries such as the U.S., Mexico and Canada.

Europe is at one of the lower echelons of the global ink solvent market in terms of revenue. However, region remains an important market for ink solvent. In recent years, the EU has taken several steps towards curbing carbon emission. Regulations that mandate the use of bio-based solvents in end-use industries has opened new avenues for eco-friendly variants.

]]>
Prototipazione Rapida: Cos'è e Perché è Importante per le Imprese Fri, 27 Mar 2020 18:09:28 +0100 http://comunicati.net/comunicati/aziende/tecnologia/626492.html http://comunicati.net/comunicati/aziende/tecnologia/626492.html switchup switchup  

Nel settore industriale, soprattutto per quello più innovativo e competitivo, realizzare prototipi perfetti e in breve tempo è sempre più necessario. La prototipazione è proprio quell'insieme di tecniche necessarie per la creazione di un prototipo fatto e finito. Un prototipo di cosa? Di qualunque macchina o componente o prodotto destinato a una successiva realizzazione in serie, su ampia scala.

La sfida che molte aziende sono chiamate a vincere oggi è proprio quella di ridurre al minimo i tempi di produzione, per arrivare sul mercato con la propria novità prima della concorrenza. In questa corsa senza sosta apparente, è importante poter avere a disposizione un modello reale dell'oggetto che si desidera vendere nel più breve tempo possibile.

Da alcuni anni, la tecnologia di stampa 3D è arrivata in soccorso delle imprese di tutto il mondo per consentire di creare in modo rapido l'esatta riproduzione tridimensionale di qualunque modello digitale elaborato al computer.

I vantaggi della prototipazione rapida con stampanti 3D professionali sono sotto gli occhi di tutti. Infatti, una stampante 3D professionale permette di:

- realizzare qualunque forma desiderata;

- abbattere i tempi di realizzazione;

- tagliare i costi economici;

- creare il prototipo del prodotto già con il materiale finale, in modo da poter testare subito l'oggetto nelle sue condizioni ideali.

 

Le tecniche principali di prototipazione rapida sono tre:

- la tecnica additiva;

- la tecnica sottrattiva;

- la tecnica per fusione.

La stampa in tre dimensioni si avvale della tecnica additiva, la più rapida, soprattutto se si tratta di realizzare piccoli lotti di prototipi. In questo caso, la stampante 3D non fa altro che recepire il modello digitale creato al computer con un apposito programma, per esempio AutoCAD o simile, per riprodurlo tramite l'aggiunta del materiale strato dopo strato: ogni strato, unito al precedente tramite apposito collante, andrà a comporre il prototipo reale, già pronto per essere collaudato dal reparto ricerca e sviluppo. Questa tecnica consente di ottenere in poco tempo prototipi di eccellente qualità e con una definizione perfetta.

Insomma, le nuove tecnologie 3D permettono di raggiungere risultati impensabili solo qualche decennio fa, a tutto vantaggio della qualità dei prodotti offerti dalle imprese sul mercato.

 

]]>
Supermicro espande le sue soluzioni di server di livello enterprise basate su SAP HANA per VMware Hyperconverged Infrastructure (HCI) Fri, 27 Mar 2020 17:55:24 +0100 http://comunicati.net/comunicati/aziende/varie/626494.html http://comunicati.net/comunicati/aziende/varie/626494.html Pr NewsWire Aziende Pr NewsWire Aziende
 

View in Browser

 

News From Super Micro Computer, Inc.

Transmitted by PR Newswire for Journalists on March 27, 2020 05:54 PM CET
 

Supermicro espande le sue soluzioni di server di livello enterprise basate su SAP HANA per VMware Hyperconverged Infrastructure (HCI)

 
 

Facilità di gestione dei database aziendali in ambienti HCI

SAN JOSE, California, 27 marzo 2020 /PRNewswire/ -- Super Micro Computer, Inc. (Nasdaq: SMCI), azienda leader nelle soluzioni di calcolo di livello enterprise ed edge computing, per lo storage, il collegamento in rete e per le tecnologie ecologiche per il calcolo ha annunciato la disponibilità di nuovi server SAP HANA® certificati da SAP per VMware HCI. Con certificazione su VMware vSphere e vSAN, i server Supermicro alimentati da processori di seconda generazione Intel Xeon Scalable che includono la memoria persistente Intel Optane permettono di integrare implementazioni SAP HANA mission-critical su HCI, dando ai clienti capacità di database di azienda e l'opportunità di sfruttare il valore, i vantaggi e la semplicità di HCI per i loro carchi di lavoro SAP.

"Grazie ai server Supermicro certificati per VMware HCI alimentati da vSAN, i clienti SAP dispongono ora delle migliori soluzioni per le aziende per scalare, gestire e virtualizzare in modo efficiente le loro infrastrutture SAP per il massimo ritorno sugli investimenti," ha affermato Raju Penumatcha, Vicepresidente senior e responsabile capo prodotto presso Supermicro.

I sistemi SYS-2029U-E1CRT e SYS-6029U-E1CRT4 di Supermicro sono stati certificati su VMWare vSAN version 6.6, vSphere version 6.7, e SAP HANA 2.0. Supermicro è uno dei primi produttori di hardware ad usare i nuovi processori di seconda generazione Intel Xeon Scalable e la memoria persistente Intel Optane per permettere alle aziende di raggiungere maggiore prestazione, capacità e valore dalle loro implementazioni SAP HANA. Inoltre, dato che le CPU includono le esclusive capacità integrate di accelerazione IA di Intel DL Boost, queste piattaforme forniscono l'agilità necessaria per estrarre ulteriori informazioni dai carichi di lavoro dotati di IA.

"SAP riconosce che HCI è una delle architetture aziendali in più rapida crescita del settore," ha dichiarato Martin Heisig, Responsabile di SAP HANA Technology Innovation Network. "Durante l'implementazione di SAP S/4HANA su VMware HCI, i clienti possono trarre enormi vantaggi dalle più recenti tecnologie HW/SW per aumentare la scalabilità e ridurre i costi operativi per le implementazioni SAP HANA."

La collaborazione di Supermicro con VMware offre un'alternativa all'infrastruttura di virtualizzazione tradizionale basata su Fiber Channel SAN, conosciuta per la sua complessità e le sfide di interoperabilità. HCI alimentato da VMware vSAN riunisce il calcolo, lo storage e l'hypervisor in un unico sistema per ridurre la complessità del data center e aumentare la scalabilità. Questo approccio permette di superare gli ostacoli delle architetture convenzionali, in particolare lo storage SAN e NAS, incluse le loro sfide e i loro problemi di collegamento in rete. HCI utilizza lo storage ad attacco diretto in un'architettura Software-Defined Storage (SDS) supportata dalla crescita dei server ad alta densità di storage e delle unità flash ad alte prestazioni.

"VMWare è felice di collaborare con Supermicro per proporre le ultimissime piattaforme certificate SAP HANA basate su VMware vSAN," ha affermato Lee Caswell, Vicepresidente unità marketing HCI business di VMware. "I database ad elevate prestazione sono gli ultimi carichi di lavoro a sfruttare l'innegabile rapporto qualità-prezzo di Hyperconverged Infrastructure (HCI). Con VMware vSAN e Supermicro, i clienti possono eseguire le loro più grandi implementazioni DevOps e produzione SAP HANA con un massimo di 64 nodi e un massimo di 192 terabyte di memoria."

Per maggiori informazioni sulle soluzioni certificate Supermicro per SAP HANA, visitare il sito: https://www.supermicro.com/en/solutions/sap

Informazioni su Super Micro Computer, Inc. 

Supermicro (Nasdaq: SMCI), innovatore leader di tecnologie server ad alta efficienza e a prestazioni elevate è un fornitore primario di server avanzati Building Block Solutions® per centri dati, Cloud Computing, infrastrutture IT di grandi aziende, Hadoop/Big Data, HPC e sistemi integrati in tutto il mondo. Supermicro è impegnata nel rispetto dell'ambiente con l'iniziativa "We Keep IT Green®" fornendo ai clienti le soluzioni più efficienti dal punto di vista energetico ed ecologiche disponibili sul mercato.

Intel, Intel logo e Xeon sono marchi commerciali di Intel Corporation e delle sue filiali. Tutti gli altri marchi, nomi, marchi commerciali sono di proprietà dei rispettivi proprietari.

SAP e altri prodotti e servizi SAP menzionati in questo documento e i rispettivi loghi sono marchi o marchi registrati di SAP SE in Germania e in altri paesi. Visitare il sito https://www.sap.com/copyright per ulteriori informazioni e avvisi sul marchio.

VMware, vSphere, VMware vSAN sono marchi registrati di VMware, Inc., Inc. e delle sue filiali negli Stati Uniti e in altre giurisdizioni.

SMCI-F

Foto - https://mma.prnewswire.com/media/1138207/Supermicro_Expands_Enterprise_Server_SAP.jpg

SOURCE Super Micro Computer, Inc.

CONTACT: CONTATTO: Greg Kaufman, Super Micro Computer, Inc., pr@supermicro.com

Web Site: http://www.supermicro.com

 
View in Browser
 
                                                           
]]>
Terna, il Piano 2020-2024: l’AD e DG Luigi Ferraris lancia investimenti per 7,3 miliardi Fri, 27 Mar 2020 17:26:24 +0100 http://comunicati.net/comunicati/aziende/varie/626490.html http://comunicati.net/comunicati/aziende/varie/626490.html pressreleaself pressreleaself Terna sta realizzando una profonda trasformazione, ponendosi al centro della transizione energetica in atto come acceleratore chiave della stessa: l'AD e DG Luigi Ferraris lancia il Piano 2020-2024, il più alto di sempre.

Luigi Ferraris, AD Terna

Terna, il Piano 2020-2024: la presentazione dell'AD e DG Luigi Ferraris

Parla di "impegno globale" l'Amministratore Delegato e Direttore Generale di Terna Luigi Ferraris nel lanciare il Piano 2020-2024. È quello che il "mondo ci chiede per una progressiva decarbonizzazione, da realizzare il più rapidamente possibile". Questo, come spiega ancora l'AD, significa garantire efficienza in tutti i settori dell'energia: "In Italia il sistema elettrico sta attraversando un processo radicale di transizione. Da un modello centralizzato a un modello estremamente complesso, integrato e distribuito". In questo scenario le nuove tecnologie digitali giocano un ruolo fondamentale, in quanto permettono "di raccogliere informazioni a basso costo, di trasferire grandi flussi di dati e di immagazzinarli e analizzarli in modo efficace e tempestivo". La crescente penetrazione delle energie green apre dunque a importanti sfide per la gestione del sistema elettrico, con un impatto molto significativo sulle attività dell'operatore di reti di trasmissione (TSO): l'impatto delle rinnovabili sulla stabilità della rete e sull'adeguatezza del sistema, la distribuzione geografica delle rinnovabili e le loro caratteristiche tecniche e i cambiamenti climatici. Per affrontarle secondo Luigi Ferraris "tutti i principali attori del settore dell'energia dovranno lavorare, in modo sistemico e in stretto coordinamento tra loro, con l'obiettivo di mettere in atto immediatamente una serie di azioni per garantire l'adeguatezza, la qualità, l'efficienza e la sostenibilità del sistema".

Terna, l'AD e DG Luigi Ferraris: 7,3 miliardi di euro per lo sviluppo della rete elettrica

"Terna porterà avanti la sua missione, esercitando un ruolo guida per una transizione energetica sostenibile, facendo leva su innovazione, competenze e tecnologie distintive": sono questi i pilastri indicati dall'AD e DG Luigi Ferraris alla base del Piano 2020-2024. "Un impegno da 7,3 miliardi di euro che rappresenta un record di investimenti in linea con il Green New Deal e con la strategia nazionale per la decarbonizzazione e che si concretizza in ricadute importanti per lo sviluppo del territorio e nella generazione di ulteriore valore per i nostri azionisti" ha detto l'AD e DG di Terna. Si tratta di un aumento di circa il 20% rispetto al precedente Piano Strategico: "Con l'incremento della spesa e la valorizzazione delle nostre competenze core, sia in Italia che all'estero, puntiamo a raggiungere una crescita del margine operativo lordo superiore al 4% medio annuo nel periodo di piano". Luigi Ferraris ha infine ricordato "l'entusiasmo e la passione delle persone che lavorano in, e per, il Gruppo" sottolineando il loro valore nell'affrontare e vincere le sfide future: "Ci impegniamo perché Terna possa continuare a svolgere il ruolo fondamentale che le compete, da TSO, generando valore per tutti i nostri azionisti".

]]>